A Study of XmAb23104 in People With Sarcoma
Phase 2 Terminated
6 enrolled 9 charts
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Phase 1/2 Terminated
53 enrolled 23 charts
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
94 enrolled 28 charts
PROACT
Phase 2 Terminated
49 enrolled 12 charts
Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction
Phase 4 Terminated
12 enrolled 6 charts
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Phase 1/2 Terminated
87 enrolled 29 charts
Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
Phase 1/2 Terminated
19 enrolled 26 charts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
PLX3397
Phase 1/2 Terminated
39 enrolled 13 charts
MANTRA
Phase 3 Terminated
175 enrolled 16 charts
A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Phase 1 Terminated
9 enrolled 10 charts
TTI-621-03
Phase 2 Terminated
76 enrolled 53 charts
MODULATE
Phase 1/2 Terminated
2 enrolled 7 charts
Milademetan in Advanced/Metastatic Solid Tumors
Phase 2 Terminated
40 enrolled 13 charts
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
Phase 1/2 Terminated
89 enrolled 20 charts
Pazopanib Maintenance Phase II
Phase 2 Terminated
1 enrolled 4 charts
Palbociclib + Ganitumab In Ewing Sarcoma
Phase 2 Terminated
10 enrolled 15 charts
UVA-Gen001
Phase 2 Terminated
4 enrolled 16 charts
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 16 charts
A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Phase 2 Terminated
99 enrolled 10 charts
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Phase 1/2 Terminated
23 enrolled 15 charts
ALpha-T
Phase 2 Terminated
1 enrolled 5 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
VITA
Phase 3 Terminated
32 enrolled 13 charts
REVEAL
Phase 1/2 Terminated
64 enrolled 22 charts
Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
Phase 2 Terminated
6 enrolled 10 charts
A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma
Phase 2 Terminated
6 enrolled 8 charts
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
Phase 1/2 Terminated
3 enrolled 10 charts
Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum
Phase 1/2 Terminated
21 enrolled 11 charts
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Phase 1/2 Terminated
5 enrolled 9 charts
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Phase 2 Terminated
317 enrolled 27 charts
Gemcitabine Plus Ascorbate for Sarcoma in Adults
Phase 2 Terminated
10 enrolled 13 charts
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
Phase 2 Terminated
7 enrolled 5 charts
IMDZ-C232
Phase 2 Terminated
89 enrolled 24 charts
A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)
Phase 3 Terminated
1 enrolled 2 charts
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Phase 2 Terminated
7 enrolled 7 charts
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
Phase 2 Terminated
10 enrolled 6 charts
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Phase 2 Terminated
4 enrolled 9 charts
Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer
Phase 1 Terminated
6 enrolled 12 charts
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Phase 2 Terminated
5 enrolled 4 charts
A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase 2 Terminated
6 enrolled 6 charts
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Phase 2 Terminated
9 enrolled 13 charts
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall
Phase 2 Terminated
23 enrolled 6 charts
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
Phase 1 Terminated
5 enrolled 15 charts
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
Phase 2 Terminated
18 enrolled 13 charts
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
Phase 1/2 Terminated
8 enrolled 20 charts
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Phase 1/2 Terminated
5 enrolled 6 charts
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma
Phase 2 Terminated
8 enrolled 4 charts